Article Text

Download PDFPDF
72 MAST CELLS AND EOSINOPHILS STIMULATE MYOFIBROBLAST DIFFERENTIATION BY SIGNALING THROUGH THE TRANSFORMING GROWTH FACTOR b TYPE I (ALK5) RECEPTOR.
  1. M. C. Nlend,
  2. A. Nair,
  3. A. Talati,
  4. C. H. Sheen,
  5. R. Kalhan,
  6. K. Thavarajah,
  7. M. Kulka,
  8. P. H.S. Sporn
  1. Feinberg School of Medicine, Northwestern University, Chicago, IL

Abstract

Rationale Mast cells and eosinophils synthesize various mediators, including transforming growth factor b (TGF-b) and cysteinyl leukotrienes (cysLTs), that may promote subepithelial fibrosis in asthma. We sought to determine the roles of TGF-b and cysLTs in myofibroblast differentiation stimulated by coculture of fibroblasts with mast cells or eosinophils.

Methods IMR-90 human lung fibroblasts were serum starved and cocultured for 48 hours with either LAD-2 human mast cells or freshly isolated human blood eosinophils in the absence or presence of SB431542 (10 M) to block signaling through the TGF-b type I (ALK5) receptor; MK886 (1 M) to block leukotriene synthesis; MK571 (100 nM) to block the cysLT1 receptor; or Bay u9773 (3 M) to block the cysLT1 and cysLT2 receptors. a-Smooth muscle actin (a-SMA) expression was assessed as an index of myofibroblast differentiation.

Results Mast cells and eosinophils stimulated 2.50.2 (n = 5, p < .005)- and 1.80.2 (n = 5, p < .0001)-fold increases, respectively, in fibroblast a-SMA expression, determined by immunoblot analysis. In comparison, TGF-b (2.5 ng/mL) increased a-SMA expression by 5.50.5-fold (n = 6, p < .0001). SB431542 inhibited the increase in a-SMA expression stimulated by mast cells, eosinophils and TGF-b by 6,019%, 8,221% and 9,210%, respectively (all p < .0001). By contrast, none of the leukotriene pathway inhibitors significantly affected a-SMA expression. Immunofluorescence microscopy for a-SMA confirmed the immunoblot results. Conclusion: Our data indicate that mast cells and eosinophils stimulate differentiation of myofibroblasts by TGF-b signaling through the ALK5 receptor and that cysLTs are less important in this process. Inhibition of ALK5 receptor signaling may be a useful strategy to interrupt airway remodeling in asthma.

Funded by NIH R01HL072891, Crane Asthma Center of Northwestern University.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.